Hinge Health (NYSE:HNGE) Shares Gap Up – Should You Buy?

Hinge Health Inc. (NYSE:HNGE) shares gapped up before the market opened on Wednesday . The stock had previously closed at $62.78, but opened at $65.17. Hinge Health shares last traded at $64.5610, with a volume of 134,875 shares.

Analyst Upgrades and Downgrades

A number of analysts have commented on HNGE shares. Wall Street Zen downgraded Hinge Health from a “strong-buy” rating to a “buy” rating in a research report on Saturday. Needham & Company LLC boosted their target price on Hinge Health from $59.00 to $63.00 and gave the stock a “buy” rating in a research report on Wednesday, May 6th. Weiss Ratings upgraded shares of Hinge Health from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, May 6th. KeyCorp set a $55.00 price target on shares of Hinge Health in a research report on Wednesday, February 11th. Finally, Citizens Jmp upped their price objective on Hinge Health from $65.00 to $80.00 and gave the company a “market outperform” rating in a research report on Wednesday, May 6th. Two analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $68.33.

Hinge Health Stock Performance

The company has a market cap of $4.96 billion and a price-to-earnings ratio of -5.19. The stock’s fifty day simple moving average is $48.92 and its two-hundred day simple moving average is $45.63.

Hinge Health (NYSE:HNGE) last posted its earnings results on Tuesday, May 5th. The company reported $0.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.12 by $0.33. Hinge Health had a negative return on equity of 310.62% and a negative net margin of 78.95%.The business had revenue of $182.31 million during the quarter. During the same quarter last year, the business posted $1.30 EPS. Hinge Health’s quarterly revenue was up 47.2% compared to the same quarter last year. Analysts predict that Hinge Health Inc. will post 1.21 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, CEO Daniel Antonio Perez sold 104,544 shares of the business’s stock in a transaction dated Wednesday, May 6th. The shares were sold at an average price of $55.09, for a total value of $5,759,328.96. Following the completion of the sale, the chief executive officer owned 35,470 shares of the company’s stock, valued at approximately $1,954,042.30. The trade was a 74.67% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Chairman Gabriel M.I. Mecklenburg sold 83,334 shares of the business’s stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $60.22, for a total transaction of $5,018,373.48. Following the completion of the sale, the chairman directly owned 83,334 shares of the company’s stock, valued at $5,018,373.48. The trade was a 50.00% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 554,600 shares of company stock worth $29,859,068 in the last quarter. 18.92% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the company. Wells Fargo & Company MN lifted its holdings in Hinge Health by 160.0% during the 4th quarter. Wells Fargo & Company MN now owns 546 shares of the company’s stock worth $25,000 after buying an additional 336 shares during the last quarter. Caitong International Asset Management Co. Ltd acquired a new stake in Hinge Health during the fourth quarter worth about $26,000. CENTRAL TRUST Co acquired a new stake in Hinge Health during the first quarter worth about $37,000. First Horizon Corp raised its stake in Hinge Health by 163.9% during the fourth quarter. First Horizon Corp now owns 855 shares of the company’s stock worth $40,000 after acquiring an additional 531 shares during the period. Finally, High Point Wealth Management LLC acquired a new stake in Hinge Health during the fourth quarter worth about $46,000.

About Hinge Health

Hinge Health (NYSE: HNGE) is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company’s platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.

Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.